Avalo Therapeutics Inc

AVTXNASDAQ · US

Holders

ACQUIREDT+30
Sullivan Christopher Ryan
Avalo Therapeutics Inc · NASDAQ
+12,394 sh · $122.5K
Filed 18 Sept 2026SEC Form 4view source
REDUCEDT+30
Sullivan Christopher Ryan
Avalo Therapeutics Inc · NASDAQ
−12,394 sh · $202.4K
Filed 18 Sept 2026SEC Form 4view source
REDUCEDStale
Sullivan Christopher Ryan
Avalo Therapeutics Inc · NASDAQ
−10,185 sh · $179.5K
Filed 11 Sept 2026SEC Form 4view source
ACQUIREDStale
Sullivan Christopher Ryan
Avalo Therapeutics Inc · NASDAQ
+10,185 sh · $81.9K
Filed 11 Sept 2026SEC Form 4view source
REDUCEDStale
Doyle Mittie
Avalo Therapeutics Inc · NASDAQ
−679 sh · $13.6K
Filed 1 Sept 2026SEC Form 4view source
ACQUIREDStale
Doyle Mittie
Avalo Therapeutics Inc · NASDAQ
+679 sh · $5.5K
Filed 1 Sept 2026SEC Form 4view source
ACQUIREDStale
Sullivan Christopher Ryan
Avalo Therapeutics Inc · NASDAQ
+31,031 sh · $306.6K
Filed 19 Aug 2026SEC Form 4view source
ACQUIREDStale
Sullivan Christopher Ryan
Avalo Therapeutics Inc · NASDAQ
+37,945 sh · $374.9K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Doyle Mittie
Avalo Therapeutics Inc · NASDAQ
−1,000 sh · $20.0K
Filed 19 Aug 2026SEC Form 4view source
REDUCEDStale
Sullivan Christopher Ryan
Avalo Therapeutics Inc · NASDAQ
−31,031 sh · $622.3K
Filed 19 Aug 2026SEC Form 4view source